Zydus Wellness fixes July 17 record date for ₹1.20 dividend
Zydus Wellness Limited has fixed July 17, 2026, as the record date for a final dividend of ₹1.20 per share, pending shareholder approval at the AGM on August 4, 2026. The board also appointed Mr. Apurva S. Diwanji as an Additional Independent Director for a five-year term.

*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has fixed Friday, July 17, 2026, as the record date to determine the eligibility of members entitled to receive the final dividend for the financial year ended March 31, 2026. The Board of Directors has recommended a final dividend of ₹1.20 per equity share, which is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).
Key Meeting Dates
The company has scheduled its Thirty Second AGM for Tuesday, August 4, 2026, at 10:00 a.m. IST via Video Conference or Other Audio Visual Means. Following the meeting, the payment of the dividend is expected to commence on or after Friday, August 7, 2026, subject to the deduction of applicable tax at source and shareholder approval.
Board Appointments
During its meeting held on May 18, 2026, the board approved the appointment of Mr. Apurva S. Diwanji as an Additional Director in the category of Non-Executive & Independent Director. His appointment is effective May 18, 2026, for a term of five years ending May 17, 2031, subject to approval by members through a special resolution. Mr. Diwanji will not be liable to retire by rotation.
Corporate Calendar
| Event | Date |
|---|---|
| Board Meeting | May 18, 2026 |
| Record Date | July 17, 2026 |
| Annual General Meeting | August 4, 2026 |
| Dividend Payment Start | On or after August 7, 2026 |
Mr. Apurva S. Diwanji brings over 32 years of experience, specializing in mergers and acquisitions, private equity, and joint ventures. He currently serves as an Independent Director on the boards of Torrent Power Limited, Bajaj Life Insurance Limited, and Bajaj General Insurance Limited, among others.
How does Zydus Wellness's ₹1.20 per share dividend compare to its historical dividend payouts, and does this signal a shift in the company's capital allocation strategy?
Given Mr. Diwanji's extensive M&A and private equity expertise, could his appointment as Independent Director indicate that Zydus Wellness is exploring potential acquisitions or strategic partnerships in the near future?
How might Mr. Diwanji's simultaneous board memberships at Bajaj Life Insurance and Bajaj General Insurance create synergistic opportunities or conflicts of interest for Zydus Wellness's business interests?





























